215% After Hours: Inovio’s First FDA-Approved Drug Sparks a Wild Rally
The FDA granted accelerated approval to Inovio's Voceryq for a rare throat disease, and the stock jumped over 200% after hours.
Voceryq
Local weather
Finding your area…National Weather Service
Trending
- College Football Week 6 Guide: Georgia-Alabama, Red River and Every Big Game to Watch
- 23% of D.R. Horton Buyers Bailed, and Rates Are the Reason
- Brabus Wants Your G-Wagen Money on the Water: A $20,490 Electric Hydrofoil, Only 77 Made
- 11 Months Old: Viral ‘Hyundai Cyberpunk 2026’ Is the CRATER Concept
- Can Trump Govern Without Congress If Democrats Win? Reuters Says Yes